Your browser doesn't support javascript.
loading
Prospective analysis of circulating metabolites and endometrial cancer risk.
Dossus, Laure; Kouloura, Eirini; Biessy, Carine; Viallon, Vivian; Siskos, Alexandros P; Dimou, Niki; Rinaldi, Sabina; Merritt, Melissa A; Allen, Naomi; Fortner, Renee; Kaaks, Rudolf; Weiderpass, Elisabete; Gram, Inger T; Rothwell, Joseph A; Lécuyer, Lucie; Severi, Gianluca; Schulze, Matthias B; Nøst, Therese Haugdahl; Crous-Bou, Marta; Sánchez, Maria-Jose; Amiano, Pilar; Colorado-Yohar, Sandra M; Gurrea, Aurelio Barricarte; Schmidt, Julie A; Palli, Domenico; Agnoli, Claudia; Tumino, Rosario; Sacerdote, Carlotta; Mattiello, Amalia; Vermeulen, Roel; Heath, Alicia K; Christakoudi, Sofia; Tsilidis, Konstantinos K; Travis, Ruth C; Gunter, Marc J; Keun, Hector C.
Afiliación
  • Dossus L; Nutrition and Metabolism Section, International Agency for Research on Cancer, Lyon, France. Electronic address: dossusl@iarc.fr.
  • Kouloura E; Cancer Metabolism and Systems Toxicology Group, Division of Cancer, Department of Surgery and Cancer, Imperial College, London, UK; European Food Safety Authority, Via Carlo Magno 1A, 43126 Parma, Italy.
  • Biessy C; Nutrition and Metabolism Section, International Agency for Research on Cancer, Lyon, France.
  • Viallon V; Nutrition and Metabolism Section, International Agency for Research on Cancer, Lyon, France.
  • Siskos AP; Cancer Metabolism and Systems Toxicology Group, Division of Cancer, Department of Surgery and Cancer, Imperial College, London, UK.
  • Dimou N; Nutrition and Metabolism Section, International Agency for Research on Cancer, Lyon, France.
  • Rinaldi S; Nutrition and Metabolism Section, International Agency for Research on Cancer, Lyon, France.
  • Merritt MA; Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.
  • Allen N; Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Fortner R; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Kaaks R; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Weiderpass E; Office of the Director, International Agency for Research on Cancer, Lyon, France.
  • Gram IT; Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Troms, Norway.
  • Rothwell JA; Centre for Research in Epidemiology and Population Health, CESP, Université Paris-Saclay, UVSQ, Inserm U1018, Villejuif, France; Gustave Roussy, Villejuif, France.
  • Lécuyer L; Centre for Research in Epidemiology and Population Health, CESP, Université Paris-Saclay, UVSQ, Inserm U1018, Villejuif, France; Gustave Roussy, Villejuif, France.
  • Severi G; Centre for Research in Epidemiology and Population Health, CESP, Université Paris-Saclay, UVSQ, Inserm U1018, Villejuif, France; Gustave Roussy, Villejuif, France; Department of Statistics, Computer Science and Applications "G. Parenti" (DISIA), University of Florence, Italy.
  • Schulze MB; Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; Institute of Nutritional Science, University of Potsdam, Potsdam, Germany.
  • Nøst TH; Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Troms, Norway.
  • Crous-Bou M; Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), Barcelona, Spain; Nutrition and Cancer Group, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston,US
  • Sánchez MJ; Escuela Andaluza de Salud Pública (EASP), Granada, Spain; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; Department of Preventive Medicine and Public Health, University of Grana
  • Amiano P; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; Public Health Division of Gipuzkoa, BioDonostia Research Institute, Donostia-San Sebastian, Spain.
  • Colorado-Yohar SM; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain; Research Group on Demography and Health, National Faculty of Public Health, University of Antioquia, Medellín
  • Gurrea AB; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; Navarra Public Health Institute, Pamplona, Spain; Navarra Institute for Health Research (IdiSNA) Pamplona, Spain.
  • Schmidt JA; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Palli D; Institute for Cancer Research, Prevention and Clinical Network - ISPRO, Cancer Risk Factors and Life-Style Epidemiology Unit, Florence, Italy.
  • Agnoli C; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy.
  • Tumino R; Cancer Registry and Histopathology Department, Provincial Health Authority (ASP) Ragusa, Italy.
  • Sacerdote C; Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO), Turin, Italy.
  • Mattiello A; Dipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy.
  • Vermeulen R; Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands.
  • Heath AK; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
  • Christakoudi S; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK; MRC Centre for Transplantation, King's College London, London, UK.
  • Tsilidis KK; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK; Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.
  • Travis RC; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Gunter MJ; Nutrition and Metabolism Section, International Agency for Research on Cancer, Lyon, France.
  • Keun HC; Cancer Metabolism and Systems Toxicology Group, Division of Cancer, Department of Surgery and Cancer, Imperial College, London, UK.
Gynecol Oncol ; 162(2): 475-481, 2021 08.
Article en En | MEDLINE | ID: mdl-34099314
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Neoplasias Endometriales Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Middle aged Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Neoplasias Endometriales Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Middle aged Idioma: En Año: 2021 Tipo del documento: Article